DEF 14A
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
What to expect at Teva's Black Friday 2023 Sale - Blacker Friday
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Completes Plan B One-Step Asset Sale To Foundation Consumer Healthcare For $675M
Milan, Italy - November 1, 2017: Teva Pharmaceutical Industries Editorial Photo - Image of logo, site: 105934406
Kare Schultz signals end to time at Teva - Globes
Teva Announces New Organization Structure and Leadership Changes | Business Wire
Teva Pharmaceutical: An Opportunity Or A Falling Knife? (NYSE:TEVA) | Seeking Alpha
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceuticals - Wikipedia
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Beyond the Pill: Teva's Use of Digitization to Add Value Back into Generic Drugs - Technology and Operations Management
Teva Pharmaceuticals Agrees To $85 Million Settlement In Opioid Case. - The Medical Times
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
End Of Schultz Era Looms For Teva :: Generics Bulletin
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
What Is Teva Pharmaceutical's Fair Value With The Impact Of Copaxone? (NYSE: TEVA) | Seeking Alpha
Three Board Members to Leave Distraught Drugmaker Teva | Ctech
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
689 Teva Images, Stock Photos & Vectors | Shutterstock
HONEY AND SILK: Winter Spirit with Teva
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report | Fierce Pharma
DEF 14A
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Definitive Proxy Statement
